GlassScriptPhysician profile
Bao Nguyen
NPI 1861848061
$62,626.50
in general payments reported to CMS, 2019-2025
20 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $413 · 2021: $4,054 · 2022: $11K · 2023: $45K · 2024: $1,357 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $37K · Food and Beverage: $5,218 · Travel and Lodging: $3,527 · Education: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $37,467.90 |
| Food and Beverage | $5,218.31 |
| Travel and Lodging | $3,527.24 |
| Education | $486.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $31,794.97 | 2021-2023 | |
| Medtronic, INC. | $11,204.30 | 2022-2025 | Attain Command + Surevalve, Aurora Ev-Icd Mri Surescan, Micra |
| Biotronik INC. | $10,243.62 | 2021-2024 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Sentus |
| Boston Scientific Corporation | $5,672.84 | 2019-2025 | Altrua 20, General - Therapies |
| Biosense Webster, INC. | $1,085.77 | 2021-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Philips North America LLC | $686.48 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $431.52 | 2019-2024 | Lifevest |
| Amgen INC. | $424.23 | 2019-2023 | Repatha |
| Abiomed | $209.68 | 2019-2022 | |
| Zoll Circulation INC | $129.25 | 2021 | |
| Inari Medical, INC. | $129.09 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $122.31 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $107.36 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $103.77 | 2020 | |
| Lantheus Medical Imaging, INC. | $98.22 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $85.83 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.63 | 2024 | Xifaxan |
| Kiniksa Pharmaceuticals International, Plc | $20.71 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $18.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bao Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.